جاهز للتشغيل
جاهز للتشغيل
A clinical study has shown that vitamin B3 (niacin) may enhance immunity against glioblastoma, one of the most aggressive types of brain cancer. The experiment involved adding niacin to traditional treatment for newly diagnosed patients, and initial results indicate a 28% improvement in the rate of disease stability compared to previous studies, with mild side effects such as skin redness and a warm sensation. The study is still in its early stages and is awaiting final results by mid-2027.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading